Fairmount Healthcare Fund, Director: Viridian Therapeutics, Inc.\DE VRDN Buy · Filed 24/01/24

Trade details

Type: Insider buy
Amount: $9,999,990
Shares · price: 476,190 sh · $21.00 a share
Held after: 1,839,954 sh
Stock: Viridian Therapeutics, Inc.\DE VRDN
Person: Fairmount Healthcare FundDirector
Trade date: 24/01/22
Filed: 24/01/24
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +34.9%

Viridian Therapeutics, Inc.\DE trades, last 26 weeks

What else happened in Viridian Therapeutics, Inc.\DE around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Fairmount Healthcare Fund's recent trades

Fairmount Healthcare FundDirector
BuyApogee Therapeutics
Buy
Apogee Therapeutics
APGE
$33.9M
1,992,734 sh
$33.9M
Filed 23/07/17
Traded 23/07/13
Fairmount Healthcare FundDirector
BuyApogee Therapeutics
Buy
Apogee Therapeutics
APGE
$15.2M
892,529 sh
$15.2M
Filed 23/07/17
Traded 23/07/13
Fairmount Healthcare FundDirector
BuyApogee Therapeutics
Buy
Apogee Therapeutics
APGE
$950.5K
55,913 sh
$950.5K
Filed 23/07/17
Traded 23/07/13